Copyright
©The Author(s) 2021.
World J Cardiol. Aug 26, 2021; 13(8): 325-339
Published online Aug 26, 2021. doi: 10.4330/wjc.v13.i8.325
Published online Aug 26, 2021. doi: 10.4330/wjc.v13.i8.325
Figure 2 Mechanism of sacubitril/valsartan on heart failure progression.
AT1: Angiotensin II type 1; HF: Heart failure; NP: Natriuretic peptide; RAAS: Renin-angiotensin-aldosterone-system; SAC/VAL: Sacubitril/valsartan.
- Citation: Usuda D, Higashikawa T, Hotchi Y, Usami K, Shimozawa S, Tokunaga S, Osugi I, Katou R, Ito S, Yoshizawa T, Asako S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Oba J, Nomura T, Sugita M. Angiotensin receptor blocker neprilysin inhibitors. World J Cardiol 2021; 13(8): 325-339
- URL: https://www.wjgnet.com/1949-8462/full/v13/i8/325.htm
- DOI: https://dx.doi.org/10.4330/wjc.v13.i8.325